Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-05-22

FDA Approved: LUMIZYME — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental application for Lumizyme (alglucosidase alfa) from Genzyme Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUMIZYME (ALGLUCOSIDASE ALFA)

Snippet

SUPPL AP for LUMIZYME (ALGLUCOSIDASE ALFA)